Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Chemistry Central Journal|December 21, 2018
Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives as novel antitubercular agents: future DprE1 inhibitorsJineetkumar Gawad, Chandrakant BondeThe Indian Journal of Tuberculosis|January 16, 2018
Current Affairs, Future Perspectives of Tuberculosis and Antitubercular AgentsJineetkumar Gawad, Chandrakant BondeChemistry Central Journal|June 25, 2018
Decaprenyl-phosphoryl-ribose 2'-epimerase (DprE1): challenging target for antitubercular drug discoveryJineetkumar Gawad, Chandrakant BondeCell Biochemistry and Function|January 19, 2026
Targeting Estrogen Pathways in Breast Cancer: A Review of Current Therapies and Emerging StrategiesMaitri Dabhi, Ishvarchandra Parmar, Chandrakant BondeJournal of Chromatographic Science|June 24, 2022
A New Strategy for the Software-Assisted LC Separations of Ketoconazole and Its ImpuritiesRoopali Agrawal, Sateesh Belemkar, Chandrakant BondeCurrent Drug Delivery|October 17, 2017
Formulation, Optimization and Evaluation of Organogel for Topical Delivery of AcyclovirSmita Bonde, Nisarg Mavani, Chandrakant BondeThe Indian Journal of Tuberculosis|December 2, 2022
Insights into development of Decaprenyl-phosphoryl-β-D-ribose 2'-epimerase (DprE1) inhibitors as antitubercular agents: A state of the art reviewChandrakant Bonde, Jineetkumar Gawad, Smita BondeMolecular Diversity|June 9, 2026
Comparative evaluation and selection of optimal QSAR-based machine learning model for liver toxicity predictionShreehari Thombre, Chandrakant Bonde, Prashant Kharkar, et al.Journal of Computer-Aided Molecular Design|July 22, 2026
Artificial intelligence in impurity prediction: current landscape, challenges, and future directionsShreehari Thombre, Chandrakant Bonde, Ritesh Bhole, et al.Pageof 1